Research findings to Therapeutic opportunity:
The study presented here suggests that MiRNA-9600, by decreasing the expression of its target genes, it may inhibit the expression of tumor suppressor Tumor necrosis factor (TNF)-α-induced protein 8-like 2 (TNFAIP8L2, TIPE2).
[easy_payment currency=”USD”]
Thereby, it may inhibit cell cycle progression, proliferation, and promote apoptosis of cancer cells. Thus, pharmacological formulations encompassing “MiRNA-9600 activators” may be used to inhibit cancer progression.
Details of the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Undisclosed mechanistic information: How does MiRNA-9600 increase the expression of TNFAIP8L2/TIPE2?
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Amount: $2
For purchase and payment details, you may reach us at info@genomediscovery.org
References:
Citation: Boominathan, L., Anticancer therapy: MiRNA-9600 increases the expression of tumor suppressor TNFAIP8L2/TIPE2, inhibits proliferation, and promotes apoptosis of cancer cells via down regulation of its target gene, 7/February/2017, 10.36 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org or newbioideas.com/
Courtesy: When you cite drop us a line at info@genomediscovery.org